US FDA approves Regeneron's blood cancer therapy – Reuters

Written by

admin

in

  1. US FDA approves Regeneron’s blood cancer therapy  Reuters
  2. Regeneron bispecific approved for myeloma; Concentra to buy IGM  BioPharma Dive
  3. FDA Grants Accelerated Approval to Lynozyfic for Multiple Myeloma  Curetoday
  4. FDA Approves Linvoseltamab to Treat R/R Multiple Myeloma  AJMC
  5. Regeneron announces FDA accelerated approval for Lynozyfic  TipRanks

Continue Reading

More posts